Skip to content

Alatus VBP-40

by Angiodynamics, Inc.

Alatus VBP-40 is a medical device (FDA Class II) made by Angiodynamics, Inc., cleared under FDA 510(k) K092534 on 7 Dec 2009 and listed in FDA GUDID since 2 Jan 2024 (UDI-DI H787VBP400), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K092534

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberH787VBP400 UDI-DI Date2 Jan 2024ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK092534 Date7 Dec 2009DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K092534 decided 7 Dec 2009 Active
  • FDA GUDID UDI-DI H787VBP400 listed 2 Jan 2024 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K092534
  2. Listed FDA GUDID H787VBP400

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Alatus
Generic name
Radiation therapy lesion localization urethral catheter, planning
Model / reference
VBP-40
Primary DI / UDI-DI
H787VBP400
510(k) Number
FDA product code
JAQ, IYE
GMDN term
Radiation therapy lesion localization urethral catheter, planning
Device class
Class II
Regulation number
892.5700, 892.5050
GUDID distribution status
In Commercial Distribution
MRI safety
MR Conditional

Similar devices

Other devices filed under FDA product code JAQ (System, applicator, radionuclide, remote-controlled).

Other devices from Angiodynamics, Inc.

See all devices from Angiodynamics, Inc. →

Properties

  • Single use
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)